(2) Complementary to this discovery approach, we performed validation measurements in the genetically characterized flow-sorted CD138+/CD319+ big (myeloma; mostly hyperdiploid) and small (mostly diploid) cells from four patients (Fig. 4b, Extended Data Fig. 2e and Fig. 2e). Here, SLAMF7 is linked to plasma cell myeloma.